SS

Sriramula Sravanthi

Active Director Director DIN 11030439
DIN 11030439 First appointment Mar 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sriramula Sravanthi

Data last updated:

Sriramula Sravanthi is a Director at Neptus Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11030439
Primary Designation Director
Industry Pharma
First Appointment 31 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Mar 20252025Active

Board colleagues of Sriramula Sravanthi

NameDINCompanyDesignation
Padma Chinthapally11030440Neptus Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Neptus Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sriramula Sravanthi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sriramula Sravanthi

Sriramula Sravanthi currently holds 1 directorship: Neptus Pharmaceuticals Private Limited (Director, since 31 Mar 2025).

Sriramula Sravanthi was first appointed on 31 Mar 2025 as Director at Neptus Pharmaceuticals Private Limited.

The current boards of Sriramula Sravanthi's companies include Padma Chinthapally (Neptus Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available